Loading clinical trials...
Loading clinical trials...
Tomographic Evaluation of Apexogenesis With Human Treated Dentin Matrix in Young Permanent Molars
Assess tomographic outcomes of pulpotomy in young permanent molars using human-treated dentin matrix versus MTA.
The study was conducted as a split-mouth randomized clinical trial, approved by research ethics committee, Faculty of Dentistry, Tanta University, and carried out at Pediatric Dentistry Department, Faculty of Dentistry, Tanta University. The material preparation was conducted at Pharmaceutical Technology Department, Faculty of Pharmacy, Tanta University. 20 children of both sexes aged from 6 to 8 years old were selected with bilateral deeply carious young permanent mandibular first molars that are indicated for pulpotomy procedure.The selected deeply carious molars were randomly divided into two groups as follows: Group I (Study group): 20 molars were treated with hTDM. Group II: (Control group): 20 molars were treated with White MTA. The participating cases were evaluated clinically 3, 6, 12 and 18 months. Digital periapical radiographs was taken at 6 month follow-up period to ensure the state of the treated teeth or if there was necessary condition. Tomographic evaluation was performed immediate postoperatively and at 18 months.
Age
6 - 8 years
Sex
ALL
Healthy Volunteers
Yes
Faculty of Dentistry, Tanta University
Tanta, El Gharbia, Egypt
Start Date
January 18, 2022
Primary Completion Date
June 18, 2023
Completion Date
October 18, 2023
Last Updated
July 31, 2024
20
ACTUAL participants
human treated dentin matrix
DRUG
Mineral Tri-Oxide Aggregate
DRUG
Lead Sponsor
Tanta University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions